Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 52.46MNet Cash Flow - Investing
VS
Market
Sector
Industry
History
$ 9.84Close
$ 2.51 - $ 10.09 52-Week Range
Ticker Information
Ticker
FDMTCompany Name
4D MOLECULAR THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQ4D MOLECULAR THERAPEUTICS INC - Net Cash Flow - Investing Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
FDMT - CF - Investing Historical data
| Date | Net Cash Flow - Investing |
|---|---|
| 6/30/2025 | $ 52.46M |
| 3/31/2025 | $ -7.23M |
| 12/31/2024 | $ -302.44M |
| 9/30/2024 | $ -316.18M |
| 6/30/2024 | $ -313.5M |
| 3/31/2024 | $ -190.67M |
| 12/31/2023 | $ 115.72M |
| 9/30/2023 | $ 86.62M |
| 6/30/2023 | $ 72.01M |
| 3/31/2023 | $ 80.19M |
Key Performance Insights, Last 5 Years
- 4D MOLECULAR THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Investing stands at $ -1M.
- Over the past 5 years, 4D MOLECULAR THERAPEUTICS INC's average CF - Investing has been $ -86.02M.
- The median CF - Investing for 4D MOLECULAR THERAPEUTICS INC during this period was $ -17.05M
- 4D MOLECULAR THERAPEUTICS INC reached its highest CF - Investing over the past 5 years at $ 115.72M.
- The lowest CF - Investing recorded by 4D MOLECULAR THERAPEUTICS INC in the same timeframe $ -316.18M
4D MOLECULAR THERAPEUTICS INC's CF - Investing vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Investing Benchmarks
Similar metrics to CF - Investing:
- Net Cash Flow - Financing - [Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.
- Net Cash Flow - Investment Acquisitions and Disposals - [Cash Flow Statement] A component of cash flow from investing [NCFI], representing the cash inflow (outflow) from disposal (acquisition) of investments. Includes marketable securities and loan originations.
- Net Cash Flow - Change in Cash & Cash Equivalents - [Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]
- Net Cash Flow - Operations - [Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.
- Net Cash Flow - Exchange Rate Changes on Cash - [Cash Flow Statement] Refers to the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
Definition of Net Cash Flow - Investing
[Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].FDMT - Net Cash Flow - Investing, Last 5 years
$ -316.18M
Minimum
Sep 30, 2024
$ 115.72M
Maximum
Dec 31, 2023
$ -86.02M
Average
$ -17.05M
Median
CF - Investing Benchmark AnalysisMarket
The chart above depicts the distribution of CF - Investing for companies in the Total Stock Market. The average CF - Investing of the companies is $ -35.29M with a standard deviation of $ 83.34M.
The following table provides additional summary stats:
CF - Investing in the Market:
| filtered constituents | 3.17K |
|---|---|
| min | $ -292.23M |
| max | $ 241M |
| average | $ -35.29M |
| median | $ -6.38M |
| std | $ 83.34M |